Weber, J., Thompson, J. A., Hamid, O., Berman, D., Amin, A., Ron, I., Ridolfi, R., Assi, H., Maraveyas, A., Minor, D., Siegel, J., & O'Day, S. J. (2009). A randomized, double-blind, placebo-controlled, phase II study comparing the tolerability and efficacy of ipilimumab administered with or without prophylactic budesonide in patients with unresectable stage III or IV melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 15(17), 5591-5598. https://doi.org/10.1158/1078-0432.CCR-09-1024